HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  Western and Central Africa  /  GIN

Guinea

Guinea's statistical yearbook, published by the national statistics institute, counts pregnant women living with HIV who received antiretrovirals in all eight regions, citing the health ministry's information system. Our project reads 2022 to 2024 only. The same table in the yearbook runs back to 2014, but the earlier years came from a different programme source, and several of the earlier figures are too large to be counts of women. A series joined across 2021 and 2022 would therefore show a fall that reflects a change of source and not a change in care.

130,000
People living with HIV, 2025
WHO Global Health Observatory
80.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$1.2m
United States HIV disbursements, 2026
ForeignAssistance.gov
$30.7m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$0$10m$20m$30m200120042007201020132016201920222025$30.7m$4.5m$25.3m$1.2m
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2001 — — — $5.8m
2002 $6.3m $4.0m — $312k
2003 $8.3m $6.1m $401k $9.6m
2004 $8.6m $5.9m $986k $9.0m
2005 $10.2m $6.1m $2.2m $5.9m
2006 $8.7m $7.2m — $7.5m
2007 $6.1m $1.9m $1.3m $2.5m
2008 $6.0m $1.3m $1.0m $1.2m
2009 $6.9m $3.7m $1.3m $3.9m
2010 $7.2m $3.5m $1.5m $1.0m
2011 $10.5m $1.5m $5.9m $4.0m
2012 $7.0m $775k $1.2m $519k
2013 $14.2m $2.5m $7.8m $1.8m
2014 $11.1m $644k $8.0m $1.5m
2015 $12.8m $113k $11.6m $152k
2016 $22.6m $81k $21.7m $130k
2017 $14.0m $895k $12.0m $833k
2018 $13.1m $70k $12.4m $70k
2019 $15.0m $211k $13.4m $211k
2020 $14.6m $85k $14.1m $60k
2021 $25.5m $370 $24.9m $159k
2022 $31.7m $6k $31.2m $284k
2023 $32.6m $671k $30.6m $1.1m
2024 $30.7m $4.5m $25.3m $4.9m
2025 — — — $284k
2026 — — — $1.2m

26 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
050k100k150k200020032006200920122015201820212024130,00099,000
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 69,000 55,000 85,000 —
2001 72,000 60,000 87,000 —
2002 77,000 65,000 92,000 —
2003 81,000 68,000 96,000 —
2004 85,000 72,000 98,000 —
2005 88,000 74,000 100,000 —
2006 91,000 78,000 110,000 —
2007 95,000 81,000 110,000 —
2008 98,000 85,000 110,000 —
2009 100,000 88,000 120,000 —
2010 110,000 92,000 120,000 20,000
2011 110,000 95,000 120,000 23,000
2012 110,000 98,000 130,000 28,000
2013 120,000 100,000 130,000 28,000
2014 120,000 100,000 130,000 32,000
2015 120,000 110,000 140,000 33,000
2016 120,000 110,000 140,000 37,000
2017 130,000 110,000 140,000 42,000
2018 130,000 110,000 150,000 43,000
2019 130,000 110,000 150,000 55,000
2020 130,000 110,000 150,000 62,000
2021 130,000 110,000 150,000 70,000
2022 130,000 110,000 150,000 82,000
2023 130,000 110,000 160,000 88,000
2024 130,000 110,000 160,000 99,000

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
0%20%40%60%80%2010201220142016201820202022202476.0%74.0%
  • Diagnosed
  • On treatment
YearDiagnosedOn treatment
2010 21.0% 19.0%
2011 25.0% 21.0%
2012 29.0% 25.0%
2013 32.0% 24.0%
2014 35.0% 27.0%
2015 38.0% 28.0%
2016 40.0% 30.0%
2017 43.0% 33.0%
2018 45.0% 34.0%
2019 50.0% 43.0%
2020 56.0% 48.0%
2021 59.0% 54.0%
2022 65.0% 62.0%
2023 71.0% 66.0%
2024 76.0% 74.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Guinea

3,557 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,371 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 799 26 2000–2024 aidsinfo.unaids.org 2026-10-20
WHO Global Health Observatory Modelled estimate 249 12 2000–2025 ghoapi.azureedge.net 2026-10-12
Demographic and Health Surveys Survey 238 4 2005–2018 api.dhsprogram.com 2026-10-16
UNAIDS HIV sub-national estimates viewer (Naomi) Modelled estimate 189 7 2025 nmviewerserver.azurewebsites.net 2026-10-14
WHO Global Tuberculosis Programme Programme record 168 17 2000–2025 extranet.who.int 2026-10-16
Global Fund Data Service Programme record 100 11 2017–2025 fetch.theglobalfund.org 2026-10-12
ForeignAssistance.gov Expenditure account 77 4 2001–2026 foreignassistance.gov 2026-10-29
OECD Creditor Reporting System Expenditure account 67 3 2002–2024 sdmx.oecd.org 2026-10-12
WHO Global Health Expenditure Database Expenditure account 63 7 2013–2021 apps.who.int 2026-10-12
IATI, through d-portal Expenditure account 55 3 2003–2026 d-portal.org 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
WHO HIV testing services dashboard Programme record 43 5 2018–2024 eic-database-290813.ew.r.appspot.com 2026-10-14
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 42 11 2016–2024 hivfinancial.unaids.org 2026-10-12
Guinea statistical yearbook Programme record 27 1 2022–2024 stat-guinee.org 2026-10-12
UNAIDS Data 2025 country databook Expenditure account 14 3 2016–2022 aidsinfo.unaids.org 2026-10-15
Global Fund allocations Expenditure account 4 1 2017–2026 fetch.theglobalfund.org 2026-10-12

Indicators held

79 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $79k (2024)
Budget required for collaborative TB/HIV activities Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $144k (2025)
Country-reported HIV expenditure, all sources Financing USD 16 2012–2024 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $27.8m (2024)
Domestic funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $137k (2024)
Domestic public HIV expenditure Financing USD 12 2016–2024 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $796k (2024)
Expected Global Fund funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $2.7m (2025)
Expected USAID funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $0 (2025)
Expected domestic funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $100k (2025)
Expected funding for collaborative TB/HIV activities Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $144k (2025)
External HIV and STD spending, national health accounts Financing USD 9 2013–2021 WHO Global Health Expenditure Database $16.9m (2021)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $30.7m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 17 2005–2025 IATI, through d-portal $1.6m (2025)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 15 2012–2026 IATI, through d-portal $147k (2026)
External HIV financing from the United States (ODA) Financing USD 49 2001–2026 ForeignAssistance.gov, OECD Creditor Reporting System $1.2m (2026)
Funding received for collaborative TB/HIV activities Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $79k (2024)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 4 2017–2026 Global Fund allocations 46,090,479 (2026)
Global Fund HIV disbursements to the country Financing USD 50 2003–2026 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $12.1m (2026)
Global Fund funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $1.9m (2024)
Government HIV and STD spending as a share of government health spending Financing percent 9 2013–2021 WHO Global Health Expenditure Database 2.8% (2021)
Government HIV and STD spending, national health accounts Financing USD 9 2013–2021 WHO Global Health Expenditure Database $3.1m (2021)
HIV and STD spending as a share of all external health spending Financing percent 9 2013–2021 WHO Global Health Expenditure Database 12.3% (2021)
HIV and STD spending as a share of all health spending Financing percent 9 2013–2021 WHO Global Health Expenditure Database 6.5% (2021)
HIV and STD spending, national health accounts Financing USD 9 2013–2021 WHO Global Health Expenditure Database $39.4m (2021)
HIV spending on critical enablers Financing USD 1 2017 UNAIDS Global AIDS Monitoring expenditure database $182k (2017)
HIV spending on governance and sustainability Financing USD 3 2017–2024 UNAIDS Global AIDS Monitoring expenditure database $10.2m (2024)
HIV spending on prevention Financing USD 2 2022–2024 UNAIDS Global AIDS Monitoring expenditure database $1.1m (2024)
HIV spending on prevention of vertical transmission Financing USD 2 2016–2017 UNAIDS Global AIDS Monitoring expenditure database $1.5m (2017)
HIV spending on treatment, care and support Financing USD 6 2016–2024 UNAIDS Global AIDS Monitoring expenditure database $16.5m (2024)
International HIV expenditure (country-reported) Financing USD 12 2016–2024 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $27.0m (2024)
Other bilateral HIV expenditure (country-reported) Financing USD 2 2020–2024 UNAIDS Global AIDS Monitoring expenditure database $9.4m (2024)
Private HIV and STD spending, national health accounts Financing USD 9 2013–2021 WHO Global Health Expenditure Database $19.4m (2021)
Private HIV expenditure (country-reported) Financing USD 4 2016–2017 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $24k (2017)
US HIV disbursements managed by USAID Financing USD 24 2001–2026 ForeignAssistance.gov $0 (2026)
US HIV disbursements managed by other US agencies Financing USD 24 2003–2026 ForeignAssistance.gov $48k (2026)
US HIV disbursements managed by the State Department Financing USD 3 2024–2026 ForeignAssistance.gov $1.2m (2026)
USAID funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $0 (2024)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 1 2025 WHO Global Health Observatory 71.0% (2025)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 96 2000–2025 UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), WHO Global Health Observatory 80.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 56 2010–2025 UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), WHO Global Health Observatory 82.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 19 2003–2024 UNAIDS AIDSinfo 66.1% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 2 2022–2024 UNAIDS AIDSinfo 19.7% (2024)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 6 2014–2024 UNAIDS AIDSinfo 6.1% (2024)
% of people newly enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 3 2017–2024 UNAIDS AIDSinfo 19.7% (2024)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 1 2025 WHO Global Health Observatory 89.0% (2025)
% of returned HIV test results that were positive Treatment cascade percent 31 2018–2024 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 3.0% (2024)
HIV self-test kits distributed Treatment cascade count 2 2019–2022 WHO HIV testing services dashboard 152 (2022)
HIV tests performed at a health facility Treatment cascade count 6 2018–2024 WHO HIV testing services dashboard 771,539 (2024)
HIV tests performed through community outreach Treatment cascade count 3 2019–2023 WHO HIV testing services dashboard 48,920 (2023)
HIV tests performed with the result returned to the person Treatment cascade count 39 2017–2024 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 771,539 (2024)
HIV-exposed infants tested within two months of birth Treatment cascade percent 15 2010–2024 UNAIDS AIDSinfo 50.0% (2024)
HIV-positive TB patients started or continued on ART Treatment cascade count 19 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 2,681 (2025)
Key-population people tested for HIV (count over the period) Treatment cascade count 18 2017–2025 Global Fund Data Service By population group, sex or age only, to 2025
Number newly diagnosed HIV-positive (PEPFAR MER HTS_TST_POS) Treatment cascade count 3 2021–2023 Global Fund Data Service 25,365 (2023)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 105 2000–2025 Global Fund Data Service, UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), WHO Global Health Observatory, WHO Global Tuberculosis Programme 105,498 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 26 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 85.0% (2025)
People living with HIV in care screened for TB Treatment cascade count 8 2018–2025 Global Fund Data Service 8,532 (2025)
People living with HIV on ART who started TB preventive therapy Treatment cascade count 7 2019–2025 Global Fund Data Service 35,214 (2025)
People newly enrolled on ART during the year Treatment cascade count 7 2014–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 0 (2025)
People tested for HIV in the last 12 months who received the result (household survey) Treatment cascade percent 54 2005–2018 Demographic and Health Surveys By population group, sex or age only, to 2018
Pregnant women tested for HIV in antenatal care Treatment cascade percent 13 2012–2024 UNAIDS AIDSinfo 83.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 67 2010–2025 Global Fund Data Service, Guinea statistical yearbook, UNAIDS AIDSinfo, WHO Global Health Observatory 4,518 (2025)
TB patients recorded as HIV-positive Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 2,965 (2024)
TB patients with an HIV test result recorded Treatment cascade count 19 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 16,908 (2025)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 2,800 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 1,300 (2024)
HIV prevalence among a key population Epidemic estimates percent 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 150 2000–2025 Demographic and Health Surveys, UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), World Bank Open Data 1.3% (2025)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 4,500 (2024)
New HIV infections Epidemic estimates count 612 2000–2025 UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), UNICEF HIV/AIDS dataset, WHO Global Health Observatory 3,800 (2025)
People living with HIV Epidemic estimates count 708 2000–2025 UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), UNICEF HIV/AIDS dataset, WHO Global Health Observatory 130,000 (2025)
Condom use at last higher-risk sex (household survey) Prevention and outreach percent 51 2005–2018 Demographic and Health Surveys By population group, sex or age only, to 2018
Key-population members reached by prevention programmes Prevention and outreach percent 2 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Key-population people reached by outreach (count over the period) Prevention and outreach count 19 2017–2025 Global Fund Data Service By population group, sex or age only, to 2025
Male condoms distributed in a year Prevention and outreach count 4 2020–2024 UNAIDS AIDSinfo 12,871,172 (2024)
People with comprehensive correct knowledge of HIV (household survey) Prevention and outreach percent 60 2005–2018 Demographic and Health Surveys By population group, sex or age only, to 2018
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 5,300 (2025)
Estimated size of a key population Population denominators count 4 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 53 2000–2025 UNAIDS HIV sub-national estimates viewer (Naomi), World Bank Open Data 15,099,727 (2025)
Share of HIV-exposed infants who acquire HIV — percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 17.2% (2025)

Every row shown on the Guinea page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.